Adverse effects/complications · Patients presenting with acute upper gastrointestinal haemorrhage
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (AE) · general population
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Other adverse effects · people with olfactory dysfunction for less than 4 weeks following COVID‐19 infection
1 finding from 1 review
Other adverse effects · participants with olfactory dysfunction following COVID‐19 for ≤ 15 days
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse effects · women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse effects · participants with olfactory dysfunction following COVID‐19 for ≤ 15 days
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse effects · HIV‐positive and ‐negative adults and children
MVA85A showed no clear difference in serious adverse effects compared with placebo (high certainty).
1 finding from 1 review
Serious adverse effects · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine showed no clear difference in serious adverse effects compared with doxycycline; GRADE not reported.
1 finding from 1 review
Serious adverse effects · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine showed no clear difference in serious adverse effects compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review
Adverse effects at short term (6 weeks) · women with either stress‐predominant or urge‐predominant urinary incontinence
It is very uncertain whether yoga changes adverse effects at short term (6 weeks) compared with no specific active intervention (very low certainty).
1 finding from 1 review
Adverse effects: anaemia · SSNS in children
It is very uncertain whether mycophenolate mofetil changes adverse effects: anaemia compared with levamisole (very low certainty).
1 finding from 1 review
Maternal adverse events · women with idiopathic hyperprolactinemia and recurrent miscarriage history
1 finding from 1 review